Pharmacy, 6 Traian Vuia, , Bucharest, Romania 2 Cyprus University of Technology, Department of Agricultural Sciences,

Similar documents
Optimization of extraction method and profiling of plant phenolic compounds through RP-HPLC

Qualitative and quantitative determination of phenolic antioxidant compounds in red wine and fruit juice with the Agilent 1290 Infinity 2D-LC Solution

Investigation of phenolic compounds of the herbs of Veronica Genus

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

Pelagia Research Library

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Application Note. Small Molecule Pharmaceuticals. 2-Ethyl-2-phenylmalonamide Ethosuximide Primidone Carbamazepine. Carbamazepine-

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Effective use of Pharmacopeia guidelines to reduce cost of chromatographic analysis for Fluticasone propionate

Rapid Gradient and Elevated Temperature UHPLC of Flavonoids in Citrus Fruit

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

Application Note. Separation of clindamycin phosphate and process impurities. Summary. Introduction. Category Pharmaceutical analysis Matrix

Analysis of Counterfeit Antidiabetic Drugs by UHPLC with the Agilent 1220 Infinity Mobile LC

Impurity Profiling of Carbamazepine by HPLC/UV

USP purity analysis of pravastatin sodium using the Agilent 1120 Compact LC

HPLC Analysis of Sugars

Analysis of Cannabinoids in Cannabis by UHPLC Using PDA Detection

ISSN X CODEN (USA): PCHHAX. A study of the component composition of phenolic compounds obtained from Dahlia varieties Ken s Flame herb

STANDARD OPERATING PROTOCOL (SOP)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Increasing resolution using longer columns while maintaining analysis time Advantages of the wide power range of the Agilent 1290 Infinity LC System

SUPPLEMENTARY MATERIAL

Rapid Quantitative Analysis of Cannabidiol from Consumer Products Using UltraPerformance Convergence Chromatography

Analysis of Isoflavones with the PerkinElmer Flexar FX-15 UHPLC System Equipped with a PDA Detector

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

Ultrafast analysis of synthetic antioxidants in vegetable oils using the Agilent 1290 Infinity LC system

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

CONTRIBUTIONS TO THE PHARMACOGNOSTICAL AND PHYTOBIOLOGICAL STUDY ON TARAXACUM OFFICINALE (L.) WEBER

Application Note. Agilent Application Solution Analysis of fat-soluble vitamins from food matrix for nutrition labeling. Abstract.

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Maximizing chromatographic peak capacity with the Agilent 1290 Infinity LC system

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Achiral SFC: Development of an Orthogonal SFC Method for Mometasone Furoate Impurity Analysis

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Available online Research Article

Development and validation of related substances method for Varenicline and its impurities

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

Separation of Polyphenols by Comprehensive 2D-LC and Molecular Formula Determination by Coupling to Accurate Mass Measurement

A high-performance liquid chromatography (HPLC) method for determination of chlorogenic acid and emodin in Yinhuang Jiangzhi Tea

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Comparison of a UPLC Method across Multiple UHPLC Systems

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Comparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation

THIN LAYER CHROMATOGRAPHY

PRELIMINARY RESEARCH REGARDING THE THERAPEUTIC USES OF URTICA DIOICA L. NOTE I. THE POLYPHENOLS EVALUATION

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

STANDARD OPERATING PROTOCOL (SOP)

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

SUPERCRITICAL FLUID EXTRACTION OF TETRAHYDROCANNABINOL FROM MARIHUANA. DETERMINATION OF TETRAHYDROCANNABINOL AND TETRAHYDROCANNABINOL ACID

Development and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna

Title Revision n date

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Lutein Esters from Tagetes Erecta

Journal of Chemical and Pharmaceutical Research

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Application Note. Authors: C. Ledesma, M. Gibert, J.R. Gibert Ingenieria Analitica S.L. Extracts from various food products

Determination of enantiomeric purity of Timolol Maleate by Supercritical Fluid Chromatography

DEVELOPMENT OF A VALIDATED RP-HPLC METHOD FOR SEPARATION AND DETERMINATION OF PROCESS-RELATED IMPURITIES OF OMEPRAZOLE IN BULK DRUGS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

SUPPLEMENTARY MATERIAL

Continuation of Reversed-Phase HPLC Analysis Studies of Steviol Glycosides Isolated From Stevia rebaudiana Bertoni

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

Flupyradifurone. HPLC Method

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Analysis of Cannabinoids in Hemp Seed Oils by HPLC Using PDA Detection

Single laboratory validation of conductometric method for the determination of hop pellets bitter acids

A Validated Chiral Liquid Chromatographic Method for The Enantiomeric Separation of Dapoxetine Hydrochloride

HPLC to UHPLC Transfer of USP Method for Amlodipine Besylate Using the Agilent 1290 Infinity II LC

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

VITAMINES A / E IN PLASMA BY UV - FAST CODE Z18610

Transferring a Method for Analysis of DNPH-Derivatized Aldehydes and Ketones from HPLC to UHPLC

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

Simultaneous determination of triacetin, acetic ether, butyl acetate and amorolfine hydrochloride in amorolfine liniment by HPLC

Doubling the throughput of long chromatographic methods by using a novel Dual LC workflow

REVERSE PHASE HPLC METHOD FOR THE ANALYSIS OF ALFUZOSIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORMS

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

Determination of Glabridin in Licorice Root (Glycyrrhiza glabral.) Using High Performance Liquid Chromatography

A TURBIDIMETRIC METHOD FOR THE ASSAY OF MELOXICAM USING MOLYBDOPHOSPHORIC ACID

Fig.1. Denatonium benzoate (DB) chemical structure

Analysis of HMF by HPLC

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

Transcription:

FARMACIA, 2014, Vol. 62, 6 1223 RESEARCH REGARDING TARAXACUM OFFICINALE (L.) WEBER II. OPTIMUM EXTRACTION PARAMETRES OF CAFFEIC ACID DERIVATIVES USING ULTRASOUND - ASSISTED EXTRACTION NATELA STYLIANOU 1, VASSILIS GEKAS 2, ADRIANA IULIANA ANGHEL 3 *, VIORICA ISTUDOR 1 1 University of Medicine and Pharmacy Carol Davila, Faculty of Pharmacy, 6 Traian Vuia, 020956, Bucharest, Romania 2 Cyprus University of Technology, Department of Agricultural Sciences, Biotechnology and Food Science, Lemesos 3603, Cyprus 3 University of Medicine and Pharmacy Carol Davila, Faculty of Pharmacy, Department of Pharmaceutical Botany, 6 Traian Vuia, 020956, Bucharest, Romania *corresponding author: anghel_adriana_iuliana@yahoo.com Abstract Pharmacological studies confirmed the therapeutic properties of the phenolic acids from plants, and their efficiency in treatment of type 2 diabetes mellitus. Based on this and also, on the facts that Taraxacum officinale L. contains a considerable amount of caffeic acid derivatives (48.8 mg/g in the leaves) and it does not exhibit a cytotoxic activity, we aimed to obtain a pharmacological active dry extract, titrated in cichoric acid, which can be developed in a pharmaceutical product used in type 2 diabetes mellitus therapy. The aim of this work was to optimize and evaluate the extraction parameters of caffeic acid derivatives from the plant material using Ultrasound - Assisted Extraction (UAE). The effects of different parameters of caffeic acid derivatives yields, in plants extracts were investigated using an experimental design - Taguchi L 16 (4 5 ) orthogonal array design. An HPLC/UV method was employed for the qualitative and quantitative determination of caffeic acid derivatives from the liquid extracts and from the lyophilized extract. The amount of caffeic acid derivatives and cichoric acid in the dry extract was 127.0 mg/g and 107.50 mg/g. Rezumat Cercetările privind proprietățile farmacologice ale acizilor fenol-carboxilici, au demonstrat eficiența lor în tratamentul diabetului zaharat de tip II (DZ II). Plecând de la aceste informații, cunoscând conținutul speciei Taraxacum officinale L. în derivați cafeici (48,80 mg/g în frunze) precum și absența citotoxicității, ne-am propus să obținem un extract uscat farmacologic activ, titrat în acid cicoric, pe care să-l valorificăm într-un produs farmaceutic util terapiei diabetului zaharat de tip II (DZ II). Scopul acestor cercetări constă în determinarea condițiilor optime de extracție a derivaților acidului cafeic din plantă folosind ultrasunetele (UAE). De aceea am investigat rolul parametrilor de extracție asupra conținutului în principii active și a cantității de extract uscat obținute folosind planul

1224 FARMACIA, 2014, Vol. 62, 6 factorial ortogonal Taguchi L 16 (4 5 ). Identificarea și dozarea derivaților acidului cafeic din soluțiile extractive și extractul uscat prin liofilizare au fost efectuate prin metoda HPLC/UV. Cantitatea de derivați ai acidului cafeic determinată în extractul uscat a fost de 127,0 mg/g și cea de acid cicoric este de 107,50 mg/g. Keywords: Taraxacum officinale, cichoric acid, HPLC/UV Introduction Caffeic acid and its derivatives (cichoric, caftaric, chlorogenic, ferulic acids and cynarin), as well as its precursor p-cumaric acid are the most widely phenolic acids distributed in plant tissues. It is well known that these phenolic compounds are mainly responsible for the antihyperglycemic activity due to antioxidant, α-glucosidase and α-amylase inhibition properties. Also, they act on hepatic glucogenesis, have insulin stimulating properties [2-6] and do not exhibit cytotoxic activity [8]. The aim of this work was to find and evaluate the optimum parameters for extraction of caffeic acid derivatives from leaves using the Ultrasound - Assisted Extraction (UAE), to obtain a dry extract titrated in cichoric acid and to find an appropriate HPLC method in order to have a reliable and non-time consuming method for qualitative and quantitative analysis of the above mentioned compounds in liquid and dry extracts. Materials and Methods The dry plant material of Taraxacum officinale (originated from Limassol - Cyprus) was collected before the flowering stage (leaves) in March 2009 [7]. Purity and quality of the plant material were determined using the relevant methods described in European Pharmacopoeia, 7 th Edition [9]. To optimize the UAE conditions, we considered five factors and four levels that could potentially affect the extraction efficiency. The evaluated factors were: A- temperature 0 C [35, 45, 55, 65], B- extraction time - min. [15, 30, 45, 60], C- solvent type/polarity [ethanol %: 50, 60, 70, 80]; D - solid-to-solvent ratio, g/ml [ 1/25, 2/25, 3/25, 4/25]; E- number of extractions [1-4] see Table I. Taguchi L 16 (4 5 ) orthogonal array design, consisting of 16 experimental runs was used to determine the optimum extraction conditions. The extraction conditions of every run were based on the combination of different factors and levels. All extractions (experimental runs) were carried out using the Raypa Model ultrasonic cleaning bath with programmable temperatures, ranging from 0-90 0 C, time up to 15 minutes, with a frequency of 35 khz. Ethanol of different concentrations was used as a solvent in the experiment, because it is a

FARMACIA, 2014, Vol. 62, 6 1225 proper solvent for extraction of phenolic acids and also, it is safe for consumption [7, 9]. All solvents and standard substances used in the experiment were of appropriate grade, purchased from Sigma Aldrich, Germany. The samples were analysed using a Waters HPLC series system, equipped with binary gradient pump, column thermostat, autosampler, degasser, UV detector and Empower software (Waters Corporation, Milford, Ireland) for data collection. Separation was performed on a reversed phase analytical column (Sherisorb, phase ODS 2, particle 5 µm, l x i.d 15 cm x 4.6 mm). The detection and working temperature were set at λ = 320 nm / 30 0 C and the mobile phase used was the 0.01% phosphoric acid and acetonitrile with a flow rate 1mL/min. The parameters of the method were optimized in order to obtain a better resolution between peaks [7, 9]. Quantification of cichoric, caftaric, chlorogenic, p-cumaric, ferulic acids and cynarin was performed using an external standard method. The calibration curves were obtained by plotting the peak area of the standards versus their concentration, with a good linearity in the range of 0.01 mg/ml 0.1 mg/ml (R 2 > 0.999, n = 5). All standards and samples were filtered through a 0.45 µm syringe filter before injection. The identity of compounds was achieved by comparing the Retention time (Rt) of peaks from the chromatograms obtained with the standard substance and sample [Figures 1-2]. After analysing the liquid extracts from each run, a decision was made regarding the extraction conditions to be used for the preparation of the dry extract. The milled plant material (2.0 g of leaves) was extracted with 25 ml of ethanol 50%. The sample was placed in the ultrasonic cleaner (type Raypa) at 35 khz, at 55 C for 45 minutes and four consecutive extractions were performed. The freeze drying process was employed for the drying of the liquid extract, using the laboratory scale freeze dryer Christ Alpha 1-4LD plus. The Aerosil (colloidal silicon dioxide) was used as an auxiliary substance due to its high specific surface and absorbent power. The qualitative and quantitative analysis of the dry extract was performed using the same analytical method as it was mentioned above. The Minitab 16 statistical software was used for the experimental design and data analysis. The arrangement of importance of the five factors to the extracted quantity of the caffeic acid derivatives and to the quantity of cichoric acid was evaluated according to the effectiveness of each factor through the calculation of rank. The rank was assigned based on delta statistics (the highest minus the lowest average for each factor); to the highest delta it was assigned the lowest rank. The average of each response characteristic (Signal to Nose

1226 FARMACIA, 2014, Vol. 62, 6 ratios and means) for each level of each factor were calculated (Table I). The influence of the factors was determined after the evaluation of results and analysing the design. The quality of the plant material was verified and all results were within the prescribed limits [9]: foreign matter 0.4%, total ash 11.0%, ash insoluble in hydrochloric acid 3.3%, dry residue 0.17%, and loss on drying 9.0%. Sixteen experimental runs were performed in order to optimize the five individual parameters that determined caffeic acid derivatives and cichoric acid yields. All experiments were conducted in triplicate and average results were reported. Results and Discussion The obtained data from the experiments are summarized in Table I. The results have been evaluated in order to distinguish the appropriate extraction parameters. The highest amount of compounds was found in the liquid extract which was obtained using the extraction conditions from run 11. Table I. Matrix and results of orthogonal design (extraction efficiency of caffeic acid derivatives and cichoric acid) Trial No A B C D E Caffeic acid deriv., mg/g 1 35 15 50% 1/25 1 54.39 46.90 2 35 30 60% 2/25 2 59.63 51.30 3 35 45 70% 3/25 3 60.07 52.15 4 35 60 80% 4/25 4 49.98 43.40 5 45 15 60% 3/35 4 67.73 58.80 6 45 30 50% 4/25 3 62.03 52.90 7 45 45 80% 1/25 2 60.42 52.90 8 45 60 70% 2/25 1 49.44 41.70 9 55 15 70% 4/25 2 48.19 40.60 10 55 30 80% 3/25 1 19.72 16.80 11 55 45 50% 2/25 4 68.24 59.20 12 55 60 60% 1/25 3 64.62 55.80 13 65 15 80% 2/25 3 54.30 47.30 14 65 30 70% 1/25 4 62.17 53.50 15 65 45 60% 4/25 1 30.58 25.20 16 65 60 50% 3/25 2 58.70 49.70 Cichoric acid, mg/g The quantities of caffeic acid derivatives in the liquid extracts are 19.72-68.24 mg/g, and the cichoric acid was the main phenolic acid (16.80-59.20 mg/g) (Figures 1, 2).

FARMACIA, 2014, Vol. 62, 6 1227 This experiment confirmed that the extraction parameters have an essential effect on the quality of the liquid extract (yield of active compounds) which is affecting directly the quality of the dry extract. 0.08 3 5 6 AU 0.06 0.04 1 2 4 7 0.02 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 Minutes Figure 1. Chromatographic profile of standard solution UV detection at 320 nm Legend: 1-caftaric acid, 2-chlorogenic acid, 3-caffeic acid, 4-cynarin, 5- p-cumaric acid, 6-ferulic acid, 7-cichoric acid 0.30 0.20 1 7 AU 0.10 2 3 0.00 4 5 6 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 Minutes Figure 2. Chromatographic profile of the liquid extract from leaves, at 320 nm The influence of the extraction parameters on the response (extracted quantities of compounds) was stated based on the obtained results and also based on the statistical evaluation of the data: number of extractions > solvent type > solid-to-solvent ratio > temperature > extraction time (Table II). Table II. Analysis of orthogonal design (extraction of caffeic acid derivatives and cichoric acid) Cichoric acid, mg/g Caffeic acid derivatives, mg/g A B C D E A B C D E K 1 33.68 33.62 34.32 34.35 29.59 34.94 34.92 35.65 35.60 31.05 K 2 34.18 31.94 33.14 33.89 33.69 35.49 33.28 34.51 35.19 35.04 K 3 31.76 33.07 33.37 32.04 34.31 33.11 34.40 34.75 33.36 35.58 K 4 32.50 33.50 31.31 31.85 34.54 33.91 34.86 32.55 33.30 35.79 Delta 2.42 1.68 3.01 2.49 4.95 2.38 1.64 3.11 2.30 4.74 Rank 4 5 2 3 1 3 5 2 4 1 k 1 48.44 48.40 52.17 52.27 32.65 56.02 56.15 60.84 60.40 38.53 k 2 51.58 43.63 47.77 49.88 48.63 59.91 50.89 55.64 57.90 56.73 k 3 43.10 47.36 46.99 44.36 52.04 50.19 54.83 54.97 51.56 60.25 k 4 43.92 47.65 40.10 40.52 53.72 51.44 55.69 46.11 47.69 62.03

1228 FARMACIA, 2014, Vol. 62, 6 Delta 8.48 4.77 12.08 11.75 21.07 9.71 5.27 14.73 12.71 23.50 Rank 4 5 2 3 1 4 5 2 3 1 K = average of Signal to Noise ratios for each level of each factor; k = average of means for each level of each factor; delta = the highest minus the lowest average for each factor. The impact of the extraction factors: number of extractions, solid-tosolvent ratio and solvent type is statistically significant (p < 0.1) (Tables III and IV). Table III. Parameters of the statistical analysis for the extraction of cichoric acid Source DF SS MS F P Temperature 3 189.72 63.25 3.47 0.167 Extraction time 3 54.69 18.23 0.29 0.833 Solvent type 3 299.04 99.68 5.47 0.098 Solid to-solvent ratio 3 338.97 112.99 6.20 0.084 Number of extractions 3 1115.73 371.91 20.40 0.017 Total 15 1998.15 Table IV. Parameters of the statistical analysis for the extraction of caffeic acid derivatives Source DF SS MS F P Temperature 3 237.60 79.20 3.45 0.168 Extraction time 3 68.97 22.99 0.29 0.832 Solvent type 3 448.56 149.52 6.50 0.079 Solid to-solvent ratio 3 405.27 135.09 5.88 0.090 Number of extractions 3 1398.91 466.30 20.28 0.017 Total 15 2559.31 * All the factors and the interaction terms are significant at a α-level of 0.10. Using the freeze drying method, we obtained a dry extract with a high amount of caffeic acid derivatives (127.0 mg/g). The quantity of cichoric acid was also considerable (107.50 mg/g). Conclusions The assessed optimized conditions can be applied in the preparation of an extract (pilot batches). The manufacturing process of the dry extract (laboratory scale) and the HPLC/UV method of analysis are the proper ones. Based on our data, we may conclude that Taraxacum officinale is a potential source of cichoric acid. The pharmacological profile of the obtained dry extract will be evaluated in further studies. References

FARMACIA, 2014, Vol. 62, 6 1229 1. Fraisse D., Felgines C., Texier O., Lamaison J.L., Caffeoyl Derivatives: Major Antioxidant Compounds of Some Wild Herbs of the Asteraceae Family. Food and Nutrition Sciences, 2011; 2: 181-192. 2. Funke I., Melzig M.F., Traditionally used plants in diabetes therapy phytotherapeutics as inhibitors of α-amylase activity. Brazilian Journal of Farmacognosy, 2006; 16(1): 1-5. 3. Istudor V., Gird C.E., Dutu L.E., Popescu M.L., Pacel M., Sterie A., Tudor I., Fitoterapia bolilor metabolice. Ed. Tehnoplast Company SRL, Bucuresti, 2008: 42-43. 4. Iordache A.T., Istudor V., Dinu M., Ancuceanu V.R., Tudor D., Researches regarding obtaining selective extracts with hypoglycemiant properties from vegetal indigenous products (Cichorii herba and Fraxini folium). Medicine in Evolution, 2011; 17(4): 430-435. 5. Yarnell E., Abascal K., Dandellon (Taraxacum officinale and Taraxacum mongolicum). Integrative Medicine, 2009; 8(2): 35-38. 6. Un Ju J., Mi-Kyung L., Yong B.P., Seon-Min J., Myung-Sook C., Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J.P.E.T., 2006; 318(2): 476-483. 7. Stylianou N., Gekas V., Ionița C., Istudor V., Research regarding Taraxacum officinale (L.) Weber with the intention of therapeutic exploring. Note I. Studies of phenolcarboxilic acids. Farmacia, 2014; 62(2): 358-364. 8. Amim M.M., Sawhney S.S., Manmohan S.J., Comparative antioxidant power determination of Taraxacum officinale by FRAP and DTPH method. Pharmaceutica Analytica Acta, 2013; 4(3): 1000221. 9. XXX. European Pharmacopoeia 7th Edition, Council of Europe, Strasbourg, 2011: 118, 239-244, 583-593, 1193, 1218. Manuscript received: May 2014